Physician profile
Tiffanie Tam
NPI 1083033179
$2,861.30
in general payments reported to CMS, 2019-2025
18 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $134 · 2023: $237 · 2024: $1,903 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $1,035.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,527.74 | 2024 | |
| Sumitomo Pharma America, INC. | $275.07 | 2023-2025 | Gemtesa, Myfembree |
| Abbvie INC. | $231.90 | 2023-2025 | Botox |
| Medtronic, INC. | $188.95 | 2021-2022 | |
| Astellas Pharma US INC | $163.82 | 2022-2023 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $161.87 | 2024-2025 | Upsylon, Axonics, Lynx System |
| Gynesonics, INC. | $81.06 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Vertex Pharmaceuticals Incorporated | $37.82 | 2025 | |
| Therapeuticsmd, INC. | $30.73 | 2022 | |
| Bluewind Medical | $27.40 | 2025 | Revi |
| Convatec INC. | $22.20 | 2025 | |
| Hologic Sales and Service, LLC | $20.51 | 2025 | Aptima |
| Laborie Medical Technologies Corp. | $19.51 | 2025 | Eclipse |
| Valencia Technologies Corporation | $19.13 | 2025 | Ecoin Device Kit |
| Exact Sciences Corporation | $18.84 | 2023 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.44 | 2021 | |
| Organon LLC | $13.20 | 2022 | |
| Mayne Pharma Commercial LLC | $7.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffanie Tam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.